Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obervation Letter
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF
Letter to the Editor
2012:78:1;114-115
doi: 10.4103/0378-6323.90966
PMID: 22199078

Excellent response of infantile hemangioma associated with PHACES syndrome to propranolol

Saritha Mohanan, Laxman Besra, Laxmisha Chandrashekar, Devinder Mohan Thappa
 Department of Dermatology and STD, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry - 605 006, India

Correspondence Address:
Devinder Mohan Thappa
Dermatology and STD Department, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry - 605 006
India
How to cite this article:
Mohanan S, Besra L, Chandrashekar L, Thappa DM. Excellent response of infantile hemangioma associated with PHACES syndrome to propranolol. Indian J Dermatol Venereol Leprol 2012;78:114-115
Copyright: (C)2012 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

Facial segmental infantile hemangiomas are said to be associated with PHACES, a neurocutaneous syndrome comprising of Posterior fossa brain malformations, cervicofacial segmental Hemangiomas, Arterial anomalies, cardiac defects or coarctation of aorta, eye anomalies and sternal defects such as sternal clefting or supraumbilical raphe. [1] Herewith, we report a 2.5-month-old male infant with PHACES syndrome with good response of the hemangioma to treatment with propranolol.

A 2.5-month-old male infant was brought to us with a large red-colored lesion on the right side of the face and scalp from birth. He was a term baby born of a non-consanguineous marriage with assisted vaginal delivery having a birth weight of 3 kg and normal APGAR score. On physical examination, the child was active and feeding well. The head circumference was 43 cm as against the expected 38 cm at 2 months of age. There was no neurological deficit. The child had a large segmental infantile hemangioma extending over the right side of the face measuring 14 cm x 7 cm in the maximum diameter. He also had a small hemangioma on the left eyelid [Figure - 1]a. His hemogram showed a normal profile with normal platelet count. Thyroid function tests were within normal limits. Computerized axial tomography and magnetic resonance imaging of the brain revealed a cyst in the posterior fossa communicating with the fourth ventricle resulting in hydrocephalus [Figure - 2]. Echocardiograpy of the heart revealed a small patent ductus arteriosus (PDA). Eye, ear, nose and throat examination did not reveal any abnormalities.

Figure 1: (a) Large segmental infantile hemangioma involving the right side of the face and forehead. (b) Significant regression in the size of the hemangioma following administration of propranolol after 4 months
Figure 2: Computerized tomography of the brain revealing a posterior fossa cyst communicating with the fourth ventricle and dilated lateral ventricles

The infant was put on low-dose propranolol (0.17 mg/kg per dose three times daily) under careful monitoring of heart rate and blood glucose levels. The dose was gradually increased over 3 days to 2 mg/kg/ day. The child was discharged and propranolol was continued for 4 months with significant regression of the hemangioma [Figure - 1]b. Following this, surgery to correct the Dandy-Walker malformation was planned by neurosurgery, during the course of which propranolol was stopped. There was no rebound flare in the size of the plaques.

It has been estimated that 2% of all patients with hemangiomas meet the diagnostic criteria for PHACES syndrome. [2] Diagnostic criteria include the presence of hemangiomas and at least one of the extracutaneous anomalies described. Modified criteria have been proposed for definitive and possible diagnosis of PHACES syndrome. [3] Our patient had cervicofacial hemangiomas with Dandy-Walker malformation, hydrocephalus and a small PDA.

Treatment of hemangiomas of PHACES syndrome is similar to that of infantile hemangiomas. Patients have been treated with oral steroids, intralesional steroids, vincristine, interferon-α and pulse-dye laser. [2] Surgical repair has been advocated for the aortic arch anomalies after comprehensive assessment of the vasculature. [4] We considered propranolol in this patient in order to avoid the long-term complications of systemic steroids. Our patient was started on propranolol after careful work-up, monitored for side-effects and maintained on propranolol until surgery with good response. Problems commonly anticipated with propranolol are bradycardia and hypoglycemia. In the setting of PHACES, propranolol can mask signs of heart failure, worsen cardiac function or induce hypotension leading to a theoretical risk of brain infarcts in patients with anomalous cerebral vasculature. [5] There have been few recent reports of safe use of propranolol in the setting of PHACES. [6],[7] We report this case to highlight the fact that propranolol can be used in the setting of PHACES under careful monitoring.

References
1.
Miller T, Frieden IJ. Vascular tumours. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, editors. Fitzpatrick's Dermatology in General Medicine.7 th ed. New York: McGraw- Hill; 2008. p. 1164-72
th ed. New York: McGraw- Hill; 2008. p. 1164-72'>[Google Scholar]
2.
Mussa A, Baldassarre G, Rosaia De Santis L, Gastaldi R, Corrias A, Silengo MC. Four new cases of PHACES syndrome: Variable phenotypic expression and endocrine features. Acta Paediatr 2008;97:1729-33.
[Google Scholar]
3.
Metry D, Heyer G, Hess C, Garzon M, Haggstrom A, Frommelt P, et al. Consensus statement on diagnostic criteria for PHACE syndrome. Paediatrics 2009;124:1447-56.
[Google Scholar]
4.
Giardini A, Gholam C, Khambadkone S, Kostolny M. Need for comprehensive vascular assessment before surgical repair of aortic coarctation in PHACES syndrome. Pediatr Cardiol 2010;31:291-3.
[Google Scholar]
5.
Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: Risks and recommendations. Pediatr Dermatol 2009;26:610-4
[Google Scholar]
6.
Vasaiwala R, Sajja K, Setabutr P. Novel management of the microphthalmic orbit in a patient with PHACE syndrome. Ophthal Plast Reconstr Surg 2011 [In Press].
[Google Scholar]
7.
de Graaf M, Breur JM, Raphaël MF, Vos M, Breugem CC, Pasmans SG. Adverse effectsth of propranolol when used in the treatment of hemangiomas: A case series of 28 infants. J Am Acad Dermatol 2011;65:320-7.
[Google Scholar]

Fulltext Views
207

PDF downloads
81
Show Sections